UnitedHealth Group's strong Q1 performance, characterized by 9% revenue growth and 23% increase in adjusted earnings per share, is expected to have a positive impact on the stock price in the short term. The company's ability to deliver high-quality, affordable healthcare while improving patient satisfaction positions it well for sustained growth. Management's confidence in achieving full-year earnings expectations and its efforts to drive innovation, improve affordability, and enhance the patient experience also support a positive outlook. Furthermore, UnitedHealth Group's diversified business model, with a strong presence in both health benefits and health services, contributes to its resilience and potential for long-term success. 

[1]